These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 2546850)

  • 1. Effects of the benzodiazepine receptor antagonist flumazenil in hepatic encephalopathy in humans.
    Bansky G; Meier PJ; Riederer E; Walser H; Ziegler WH; Schmid M
    Gastroenterology; 1989 Sep; 97(3):744-50. PubMed ID: 2546850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Electroencephalographic study of the effect of a benzodiazepine antagonist in hepatic encephalopathy].
    Pidoux B; Zylberberg P; Valla D; Opolon P
    Neurophysiol Clin; 1989 Dec; 19(6):469-76. PubMed ID: 2559309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of benzodiazepine-receptor antagonists and partial inverse agonists on acute hepatic encephalopathy in the rat.
    Bosman DK; van den Buijs CA; de Haan JG; Maas MA; Chamuleau RA
    Gastroenterology; 1991 Sep; 101(3):772-81. PubMed ID: 1650320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amelioration of hepatic encephalopathy by pharmacologic antagonism of the GABAA-benzodiazepine receptor complex in a rabbit model of fulminant hepatic failure.
    Bassett ML; Mullen KD; Skolnick P; Jones EA
    Gastroenterology; 1987 Nov; 93(5):1069-77. PubMed ID: 2820828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Benzodiazepine antagonists in the treatment of heptic encephalopathy].
    Ferenci P; Grimm G
    Leber Magen Darm; 1989 Dec; 19(6):322-5. PubMed ID: 2575692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of hepatic encephalopathy treated with flumazenil.
    Grimm G; Ferenci P; Katzenschlager R; Madl C; Schneeweiss B; Laggner AN; Lenz K; Gangl A
    Lancet; 1988 Dec; 2(8625):1392-4. PubMed ID: 2904525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hepatic encephalopathy (HE) with the benzodiazepine antagonist flumazenil: a pilot study.
    Meier R; Gyr K
    Eur J Anaesthesiol Suppl; 1988; 2():139-46. PubMed ID: 2842130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of acute hepatic encephalopathy with flumazenil].
    Viel E; de La Coussaye JE; Bassoul B; Saissi G; Eledjam JJ
    Ann Fr Anesth Reanim; 1990; 9(4):386-9. PubMed ID: 2119157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flumazenil in the treatment of hepatic encephalopathy in children with fulminant liver failure.
    Devictor D; Tahiri C; Lanchier C; Navelet Y; Durand P; Rousset A
    Intensive Care Med; 1995 Mar; 21(3):253-6. PubMed ID: 7790615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do benzodiazepine ligands contribute to hepatic encephalopathy?
    Jones EA; Basile AS; Yurdaydin C; Skolnich P
    Adv Exp Med Biol; 1993; 341():57-69. PubMed ID: 8116487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benzodiazepine receptor antagonists for acute and chronic hepatic encephalopathy.
    Als-Nielsen B; Kjaergard LL; Gluud C
    Cochrane Database Syst Rev; 2001; (4):CD002798. PubMed ID: 11687160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzodiazepine receptor antagonists for hepatic encephalopathy.
    Als-Nielsen B; Gluud LL; Gluud C
    Cochrane Database Syst Rev; 2004; (2):CD002798. PubMed ID: 15106178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of flumazenil in subclinical to mild hepatic encephalopathic ambulatory patients. A prospective, randomised, double-blind, placebo-controlled study.
    Dursun M; Caliskan M; Canoruc F; Aluclu U; Canoruc N; Tuzcu A; Yilmaz S; Isikdogan A; Ertem M
    Swiss Med Wkly; 2003 Feb; 133(7-8):118-23. PubMed ID: 12644958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current possibilities in the therapy of hepatic encephalopathy].
    Meier PJ; Bansky G
    Schweiz Med Wochenschr; 1990 Apr; 120(15):553-6. PubMed ID: 2159659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flumazenil does not improve hepatic encephalopathy associated with acute ischemic liver failure in the rabbit.
    van der Rijt CC; de Knegt RJ; Schalm SW; Terpstra OT; Mechelse K
    Metab Brain Dis; 1990 Sep; 5(3):131-41. PubMed ID: 2273999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of the behavioral and electrophysiological abnormalities of an animal model of hepatic encephalopathy by benzodiazepine receptor ligands.
    Gammal SH; Basile AS; Geller D; Skolnick P; Jones EA
    Hepatology; 1990 Mar; 11(3):371-8. PubMed ID: 2155865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flumazenil for hepatic encephalopathy grade III and IVa in patients with cirrhosis: an Italian multicenter double-blind, placebo-controlled, cross-over study.
    Barbaro G; Di Lorenzo G; Soldini M; Giancaspro G; Bellomo G; Belloni G; Grisorio B; Annese M; Bacca D; Francavilla R; Barbarini G
    Hepatology; 1998 Aug; 28(2):374-8. PubMed ID: 9695999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flumazenil therapy for hepatic encephalopathy. A double-blind cross over study.
    Van der Rijt CC; Schalm SW; Meulstee J; Stijnen T
    Gastroenterol Clin Biol; 1995; 19(6-7):572-80. PubMed ID: 7590022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of chronic hepatic encephalopathy in dogs by the benzodiazepine-receptor partial inverse agonist sarmazenil, but not by the antagonist flumazenil.
    Meyer HP; Legemate DA; van den Brom W; Rothuizen J
    Metab Brain Dis; 1998 Sep; 13(3):241-51. PubMed ID: 9804368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous GABAergic modulators in the pathogenesis of hepatic encephalopathy.
    Rothstein JD; Olasmaa M
    Neurochem Res; 1990 Feb; 15(2):193-7. PubMed ID: 2159124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.